Biotech

All Articles

8 months after a $213M fundraise, gene editor Tome helps make cuts

.After raising $213 million in 2023-- some of the year's largest personal biotech shots-- Volume Bio...

BioMarin constructs exec crew with biotech vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of notable leadership hirings, firings and r...

Biopharma Q2 VC hit highest degree since '22, while M&ampA slowed

.Equity capital financing in to biopharma cheered $9.2 billion throughout 215 deals in the second qu...

Bicara, Zenas seek IPOs to push late-phase assets toward market

.Bicara Therapeutics and Zenas Biopharma have provided new impetus to the IPO market with filings th...

Genentech to finalize cancer cells immunology investigation department

.Genentech will definitely shut its own cancer cells immunology investigation division, and also sys...

Kezar goes down sound lump however to confirm its worth in phase 1 test

.Kezar Lifestyle Sciences is dropping its dim stage 1 sound lump medicine as the biotech goes all-in...

Acelyrin falls izokibep, drops 3rd of staff

.Despite izokibep keeping its newly found winning touch in the clinic, Acelyrin is no more concentra...

Rivus' period 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid stops preclinical work, IV system after soticlestat neglect

.Ovid Therapy currently showed final month that it was trimming its own head count as the firm brows...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Port, increasing its o...